Oren Gilad, President & CEO, Director at Aprea Therapeutics, holds 335.19K shares in Aprea Therapeutics (Ticker: APRE). Most recently, Oren Gilad Bought $500 shares of Aprea Therapeutics on Oct 24, 2024 for an estimated value of 1.96K.
What is the percentage of profitable transactions made by Oren Gilad?
The percentage of profitable transactions made by Oren Gilad is 75%.
What is the average return per transaction made by Oren Gilad?
The average return per transaction made by Oren Gilad is 3.70%.
What stocks does Oren Gilad hold?
Oren Gilad holds: APRE stocks.
What was Oren Gilad’s latest transaction?
Oren Gilad latest transaction was an Informative Buy of $1.96K.
What was Oren Gilad's most profitable transaction?
Oren Gilad’s most profitable transaction was an Informative Buy of APRE stock on October 15, 2024. The return on the trade was 28.50%.
What is Oren Gilad's role in Aprea Therapeutics?
Oren Gilad's role in Aprea Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.